NIAID Banner Logo Image

Opportunistic Infections Citation List:

October 29 - November 11, 2010

ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. In Vitro Activity of the Lipopeptide PAL-Lys-Lys-NH2; Alone and in Combination with Antifungal Agents; Against Clinical Isolates of Candida Spp. Kamysz, E., O. Simonetti, O. Cirioni, D. Arzeni, G. Ganzetti, A. Campanati, A. Giacometti, E. Gabrielli, C. Silvestri, W. Kamysz, A. Offidani, and F. Barchies. Peptides, 2010. [Epub ahead of print]; PMID[21055432].

[Pubmed]. OI_1029-111110

2. Ciclopirox olamine: an antifungal alternative against cryptococcosis. Oliveira, P.C., C.S. Medeiros, D.P. Macedo, S.L. Andrade, M.T. Correia, S.D. Mesquita, R.G. Lima-Neto, and R.P. Neves. Letters in Applied Microbiology, 2010. 51(5): p. 485-9; PMID[21039663].

[Pubmed]. OI_1029-111110

3. Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial and antifungal agents. Hilmy, K.M., M.M. Khalifa, M.A. Hawata, R.M. Keshk, and A.A. el-Torgman. European Journal of Medicinal Chemistry 2010. 45(11): p. 5243-50; PMID[20828885].

[Pubmed]. OI_1029-111110

4. Design, synthesis and in vitro evaluation of antitubercular and antimicrobial activity of some novel pyranopyrimidines. Kamdar, N.R., D.D. Haveliwala, P.T. Mistry, and S.K. Patel. European Journal of Medicinal Chemistry, 2010. 45(11): p. 5056-63; PMID[20805011].

[Pubmed]. OI_1029-111110

5. Novel antifungal activity of purpurin against Candida species in vitro. Kang, K., W.P. Fong, and P.W. Tsang. Medical Mycology, 2010. 48(7): p. 904-11; PMID[20392152].

[Pubmed]. OI_1029-111110

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

6. Synthesis and antituberculosis activity of some new pyridazine derivatives. Mantu, D., M.C. Luca, C. Moldoveanu, G. Zbancioc, and Mangalagiu. Part II. European Journal of Medicinal Chemistry, 2010. 45(11): p. 5164-8; PMID[20813433].

[Pubmed]. OI_1029-111110

7. Synthesis and pharmacological evaluation of clubbed isopropylthiazole derived triazolothiadiazoles, triazolothiadiazines and mannich bases as potential antimicrobial and antitubercular agents. Suresh Kumar, G.V., Y. Rajendra Prasad, B.P. Mallikarjuna, and S.M. Chandrashekar. European Journal of Medicinal Chemistry, 2010. 45(11): p. 5120-9; PMID[20797808].

[Pubmed]. OI_1029-111110

8. Design of novel iron compounds as potential therapeutic agents against tuberculosis. Tarallo, M.B., C. Urquiola, A. Monge, B.P. Costa, R.R. Ribeiro, A.J. Costa-Filho, R.C. Mercader, F.R. Pavan, C.Q. Leite, M.H. Torre, and D. Gambino. Journal of Inorganic Biochemistry, 2010. 104(11): p. 1164-70; PMID[20701975].

[Pubmed]. OI_1029-111110

9. Synthesis and Evaluation of Potent Ene-yne Inhibitors of Type II Dehydroquinases as Tuberculosis Drug Leads. Tran, A.T., K.M. Cergol, N.P. West, E.J. Randall, W.J. Britton, S.A. Bokhari, M. Ibrahim, A.J. Lapthorn, and R.J. Payne. ChemMedChem, 2010. [Epub ahead of print]; PMID[21053347.

[Pubmed]. OI_1029-111110

10. Inhibitors of the Salicylate Synthase (MbtI) from Mycobacterium tuberculosis Discovered by High-Throughput Screening. Vasan, M., J. Neres, J. Williams, D.J. Wilson, A.M. Teitelbaum, R.P. Remmel, and C.C. Aldrich. ChemMedChem, 2010. [Epub ahead of print]; PMID[21053346].

[Pubmed]. OI_1029-111110

Citations from the ISI Web of Knowledge Listings for O.I.

11. Antimicrobial activity of highly stable silver nanoparticles embedded in agar-agar matrix as a thin film. Ghosh, S., R. Kaushik, K. Nagalakshmi, S.L. Hoti, G.A. Menezes, B.N. Harish, and H.N. Vasan. Carbohydrate Research, 2010. 345(15): p. 2220-2227; PMID[ISI:000282922900015].

[WOS]. OI_1029-111110.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2021